Related Experiment Video
Updated: Feb 24, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid
Guo-Zhen Liu1, Ji-Zhu Liu1, Xiao-Qing Li2
1Department of Hematology, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, People's Republic of China.
Abstract:
Various eukaryotic translation initiation factors (eIFs) have been implicated in carcinoma development. Eukaryotic translation initiation factor 3 subunit D (eIF3D) has recently been shown to regulate the growth of several types of human cancer cells. However, the function of eIF3D in acute myeloid leukemia (AML) remains unclear. In this study, we investigated the expression of eIF3D in three AML cell lines and a lymphoblast cell line, and found that eIF3D was expressed in all four leukemia cell lines. To explore the role of eIF3D in AML cell proliferation, lentivirus-mediated RNA interference was applied to knock down the expression of eIF3D in U937 cells. The expression of eIF3D was significantly downregulated in U937 cells after eIF3D knockdown, as confirmed by quantitative real-time PCR (qRT-PCR) and Western blot analysis. Knockdown of eIF3D significantly inhibited proliferation of U937 cells. Furthermore, flow cytometry analysis revealed that eIF3D silencing induced cell cycle arrest at the G2/M phase, ultimately leading to apoptosis. Our results indicate that eIF3D plays a key role in the proliferation of AML cells, and suggest that eIF3D silencing might be a potential therapeutic strategy for leukemia.
Insights
Eukaryotic translation initiation factor 3 subunit D (eIF3D) drives acute myeloid leukemia (AML) cell proliferation. Silencing eIF3D inhibits AML cell growth, suggesting it as a potential therapeutic target for leukemia.
Area of Science:
- Molecular Biology
- Cancer Research
- Hematology
Background:
- Eukaryotic translation initiation factors (eIFs) are linked to cancer.
- Eukaryotic translation initiation factor 3 subunit D (eIF3D) impacts human cancer cell growth.
- The role of eIF3D in acute myeloid leukemia (AML) is not well understood.
Purpose of the Study:
- To investigate the expression of eIF3D in AML cell lines.
- To determine the functional role of eIF3D in AML cell proliferation.
- To evaluate eIF3D as a potential therapeutic target in AML.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot analysis to confirm eIF3D knockdown.
- Lentivirus-mediated RNA interference to silence eIF3D expression in U937 cells.
- Flow cytometry to analyze cell cycle progression and apoptosis.
Main Results:
- eIF3D was expressed in all tested leukemia cell lines.
- eIF3D knockdown significantly inhibited U937 cell proliferation.
- Silencing eIF3D induced G2/M phase cell cycle arrest and apoptosis.
Conclusions:
- eIF3D is crucial for the proliferation of AML cells.
- Targeting eIF3D through silencing presents a potential therapeutic strategy for leukemia.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Inhibition of Cdk Activity
Leaky Scanning

